ClinVar Miner

Submissions for variant NC_000003.12:g.(?_10146514)_(10146636_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000456791 SCV000564072 pathogenic Chuvash polycythemia; Von Hippel-Lindau syndrome 2016-09-03 criteria provided, single submitter clinical testing This variant is a gross deletion of the genomic region encompassing exon 2 of the VHL gene. This leads to an in-frame deletion, preserving the integrity of the reading frame. Deletions of exon 2 have been reported in numerous individuals and families affected with von Hippel-Lindau disease (PMID: 19764026, 19280651, 16884328, 12114495). Experimental studies have shown that deletion of exon 2 leads to expression of a stable VHL protein lacking 41 amino acid residues. This region encodes for the beta-domain of the VHL protein that is essential for proper protein function (PMID: 11024059). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.